Idera Pharmaceuticals Price to Book Ratio 2006-2021 | IDRA

Historical price to book ratio values for Idera Pharmaceuticals (IDRA) over the last 10 years. The current price to book ratio for Idera Pharmaceuticals as of October 22, 2021 is 1.17.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Idera Pharmaceuticals Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-22 0.88 1.21
2021-06-30 1.20 $0.72 1.66
2021-03-31 1.30 $0.91 1.43
2020-12-31 3.67 $-2.38 -1.54
2020-09-30 2.14 $-0.92 -2.32
2020-06-30 1.79 $-0.52 -3.47
2020-03-31 1.32 $-0.00 -280.85
2019-12-31 1.82 $-0.38 -4.84
2019-09-30 2.89 $1.30 2.22
2019-06-30 2.67 $1.66 1.61
2019-03-31 2.55 $1.99 1.28
2018-12-31 2.77 $2.35 1.18
2018-09-30 8.91 $2.75 3.23
2018-06-30 10.56 $3.13 3.37
2018-03-31 14.72 $3.66 4.02
2017-12-31 16.88 $4.40 3.83
2017-09-30 17.84 $3.32 5.38
2017-06-30 13.76 $4.00 3.44
2017-03-31 19.76 $4.84 4.08
2016-12-31 12.00 $5.55 2.16
2016-09-30 20.48 $3.29 6.23
2016-06-30 12.24 $4.03 3.04
2016-03-31 15.84 $4.79 3.30
2015-12-31 24.72 $5.51 4.48
2015-09-30 26.76 $6.26 4.27
2015-06-30 29.68 $6.94 4.27
2015-03-31 29.68 $7.69 3.86
2014-12-31 35.28 $3.66 9.64
2014-09-30 18.32 $4.92 3.72
2014-06-30 23.20 $5.76 4.03
2014-03-31 32.64 $6.49 5.03
2013-12-31 37.04 $3.92 9.45
2013-09-30 13.92 $4.74 2.94
2013-06-30 5.24 $2.47 2.12
2013-03-31 4.00 $-0.93 -4.30
2012-12-31 7.12 $0.20 34.85
2012-09-30 8.24 $-0.66 -12.57
2012-06-30 8.48 $0.60 14.24
2012-03-31 13.84 $1.61 8.58
2011-12-31 8.40 $3.48 2.41
2011-09-30 9.44 $4.82 1.96
2011-06-30 17.20 $6.22 2.77
2011-03-31 21.12 $7.81 2.70
2010-12-31 23.12 $9.60 2.41
2010-09-30 26.32 $11.12 2.37
2010-06-30 28.80 $9.57 3.01
2010-03-31 49.68 $11.04 4.50
2009-12-31 41.36 $11.28 3.67
2009-09-30 59.28 $9.70 6.11
2009-06-30 46.88 $9.37 5.00
2009-03-31 51.76 $7.76 6.67
2008-12-31 61.44 $7.57 8.11
2008-09-30 112.56 $7.17 15.70
2008-06-30 116.88 $5.25 22.28
2008-03-31 80.08 $3.79 21.14
2007-12-31 104.80 $2.86 36.60
2007-09-30 70.40 $3.88 18.16
2007-06-30 57.28 $4.77 12.01
2007-03-31 68.72 $5.70 12.05
2006-12-31 43.12 $4.79 9.01
2006-09-30 32.80 $0.11 303.14
2006-06-30 32.48 $0.15 214.81
2006-03-31 40.32 $2.14 18.86
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.046B $0.001B
Idera Pharmaceuticals, Inc. is a drug discovery and development company that is developing drug candidates to treat cancer and infectious, respiratory, and autoimmune diseases, and for use in combination with therapeutic and prophylactic vaccines. Idera's proprietary drug candidates are designed to modulate Toll-like Receptors, the body's first line of immune defense. Idera's pioneering DNA chemistry expertise enables it to identify drug candidates for internal development and creates opportunities for multiple collaborative alliances.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76